• slidebg1
    Engineering Stem Cell Technologies
    Creating tissue models to study new approaches to treat diseases that afflict the cardiovascular, neurological, immunological, and musculoskeletal systems
  • kenburns4
    Moved West
    With the help of the CIRM Research Leadership Award the lab moved in 2015 to the Gladstone Institutes
  • slidebg1
    Scalability & Biomanufacturing
    Designing new scalable methods and non-destructive analyses that are directly and immediately relevant to biomanufacturing needs
  • kenburns4
    A Magnet for Biotechnology
    Mission Bay, where the first research building opened in 2003, has bloomed into a vibrant and vital campus and magnet to the booming San Francisco Bay Area biotechnology industry
  • kenburns1
    The Gladstone Institutes
    New home of the McDevitt Laboratory
  • kenburns4
    New Biotherapeutics
    Insights into stem cell and developmental biology, facilitate new regenerative therapies, and create novel microtissue diagnostic and pharmaceutical platforms
  • slidebg1
    AIMBE Fellow
    McDevitt honored among 1,500 individuals who have made significant contributions to the medical and biological engineering community

Lab Overview

The McDevitt lab is focused on the engineering of innovative technologies to translate the morphogenic potential of stem cells as models of development and disease, as well to develop cellular and molecular therapies aimed to treat degenerative diseases and traumatic injuries. Learn more about the research.

Since stem cells are promising for a number of applications, the emphasis of the McDevitt Lab is on the development of technology platforms to advance therapies that span multiple diseases.

Our technologies are applicable to a wide variety of diseases, including cardiovascular, orthopedic and neurological disorders. Specific diseases that we can apply our research to include treatments for diabetes, chronic wounds, aging, arthritis and other autoimmune disorders. The McDevitt lab's work also has other applications, including wound healing, irritable bowel syndrome, epilepsy and bone regeneration to name just a few. Click here for a complete list of research and disease applications.


  • Overview of Stem Cell Engineering
  • Todd was 1 of 6 panelists that toured Europe and Asia to do an international assessment of the Stem Cell Engineering field.


McDevitt lab awarded a $3.5M grant from the NIH
Todd McDevitt and Bruce Conklin are launching a project to assess the safety of genome editing in human cells and tissues.
Scientists believe that the patterning of stem cell differentiation affects what kinds of cells will ultimately emerge from the differentiation process.
Todd becomes program director and co-chair of the executive committee of the joint BioE program at UCSF and UCB.